Molecular Pathogenesis of Cardiac Failure due to Gene Abnormalities

基因异常导致心力衰竭的分子发病机制

基本信息

  • 批准号:
    13470142
  • 负责人:
  • 金额:
    $ 6.27万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2003
  • 项目状态:
    已结题

项目摘要

Idiopathic cardiomyopathy was defined as cardiomyopathy of unknown etiology. Recent molecular genetic analysis has revealed that gene abnormalities are involved in the etiology and/or pathogenesis of idiopathic cardiomyopathy. As well, hypertensive cardiomyopathy may also be relevant to the gene abnormalities in the pathogenesis. In this study, we have revealed that mutations in the genes for Z-disk elements, TTN, TCAP, MLP, and Cypher, cause cardiomyopathy. Functional studies of the mutations in each disease gene have shown that hypertrophic cardiomyopathy-related mutations increase the binding ability of the Z-disk elements, whereas dilated cardiomyopathy-related mutations decrease the binding ability. It also has been demonstrated that the Z-disk plays a key role in the stretch-sensing of cardiomyocytes from the analysis of a well known dilated cardiomyopathy model of MLP deficient mice. It was suggested that the stretch-response involved phosphorylation of Z-disk proteins, because the Z-disk protein abnormalities were predicted to change the distribution of calcineurin and PKC. In addition, Ca-sensitization and -desensitization played a crucial role in the pathogenesis of cardiac hypertrophy and failure, respectively. Analysis of hypertrophied and dilated hearts from M21-transgenic mice and Dah1 salt-sensitive hypertensive rats by DNA-chip technology showed that a number of genes were involved in the pathogenesis of cardiomyopathy. One of the new genes identified to be differentially expressed in the cardiac hypertrophy and failure is a growth factor-like gene specifically expressed in the heart. We identified a mutation in that growth factor-like gene that was associated with hypertensive cardiomyopathy.
特发性心肌病定义为病因不明的心肌病。最近的分子遗传学分析表明,基因异常参与了特发性心肌病的病因和/或发病机制。高血压性心肌病的发生也可能与基因异常有关。在这项研究中,我们发现,基因突变的Z盘元件,TTN,TCAP,MLP,和Cypher,导致心肌病。对每种疾病基因突变的功能研究表明,肥厚型心肌病相关突变增加了Z盘元件的结合能力,而扩张型心肌病相关突变降低了结合能力。通过对MLP缺陷小鼠的扩张型心肌病模型的分析,也证明了Z盘在心肌细胞的牵张感知中起着关键作用。这表明牵张反应涉及Z盘蛋白的磷酸化,因为Z盘蛋白异常被预测改变钙调磷酸酶和PKC的分布。此外,钙增敏和钙脱敏分别在心肌肥厚和心力衰竭的发病机制中起着至关重要的作用。利用DNA芯片技术对M21转基因小鼠和Dah 1盐敏感性高血压大鼠的肥大和扩张心脏进行分析,发现心肌病的发病机制涉及多个基因。新发现的在心肌肥厚和心力衰竭中差异表达的基因之一是在心脏中特异表达的生长因子样基因。我们在生长因子样基因中发现了一个与高血压性心肌病相关的突变。

项目成果

期刊论文数量(64)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kimura A, Itoh-Satoh M, Hayashi T, Takahashi M, Arimura T: "Molecular etiology of idiopathic cardiomyopathy in Asian populations."J Cardiol.. 37. S139-S146 (2002)
Kimura A、Itoh-Satoh M、Hayashi T、Takahashi M、Arimura T:“亚洲人群特发性心肌病的分子病因学”。J Cardiol.. 37. S139-S146 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Knoll R, Hoshijima M, Hoffmann HM, Person V, Lorenzen-Schmidt I, Bang M-L, Hayashi T, Shiga N, Yasukawa H, Schaper W, McKenna W, Yokoyama M, Schork J, Jeffrey H, Omens J, Andrew D, McCulloch A, Kimura A, Gregorio CC, Poller W, Schaper J, Schultheless HP,
Knoll R、Hoshijima M、Hoffmann HM、Person V、Lorenzen-Schmidt I、Bang M-L、Hayashi T、Shiga N、Yasukawa H、Schaper W、McKenna W、Yokoyama M、Schork J、Jeffrey H、Omens J、Andrew D、
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
1toh-Satoh M, Hayashi T, Nishi H, et al.: "Titin mutations as the molecular basis for dilated cardiomyopathy"Biochem. Biophys. Res. Commun.. 291. 385-393 (2002)
1toh-Satoh M、Hayashi T、Nishi H 等人:“Titin 突变是扩张型心肌病的分子基础”Biochem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ogimoto A, et al.: "17-year follow-up study of a patient with obstructive hypertrophic cardiomyopathy with a deletion mutation in the cardiac myosin binding protein C gene."Circ J.. 68. 174-177 (2004)
Ogimoto A 等人:“对一名患有心肌肌球蛋白结合蛋白 C 基因缺失突变的阻塞性肥厚型心肌病患者进行的 17 年随访研究。”Circ J.. 68. 174-177 (2004)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Arimura T, Suematsu N, Zhou YB, et al.: "Identification, characterization and functional analysis of heart-specific myosin light chain phoshatase small subunit"J. Biol. Chem.. 276. 6073-6082 (2001)
Arimura T,Suematsu N,Zhou YB,等:“心脏特异性肌球蛋白轻链磷酸酶小亚基的鉴定、表征和功能分析”J。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KIMURA Akinori其他文献

Diversity of <i>ULBP5</i> in Old-World monkeys (Cercopithecidae) and divergence of the <i>ULBP</i> gene family in primates
旧世界猴(猴科)中 <i>ULBP5</i> 的多样性和灵长类动物中 <i>ULBP</i> 基因家族的分歧

KIMURA Akinori的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KIMURA Akinori', 18)}}的其他基金

Molecular pathogenesis of heart failure and arrhythmia caused by gene abnormalities
基因异常引起心力衰竭和心律失常的分子发病机制
  • 批准号:
    16H05296
  • 财政年份:
    2016
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Strategy for regulation of cardiac functional defects due to the abnormality in molecular distribution caused by gene mutations
基因突变导致分子分布异常导致心脏功能缺陷的调控策略
  • 批准号:
    25670172
  • 财政年份:
    2013
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Molecular basis for cardiac muscle diseases caused by functional abnormalities of Z-disc
Z盘功能异常引起的心肌疾病的分子基础
  • 批准号:
    23659414
  • 财政年份:
    2011
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of strategies for handling heart failure based on the molecular pathogenesis of cardiomyopathy
基于心肌病的分子发病机制制定治疗心力衰竭的策略
  • 批准号:
    22390157
  • 财政年份:
    2010
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A Parallel Point Generation Using Monte Carlo Methods for Point Based Visualization of Multiple Volume Data
使用蒙特卡罗方法生成并行点以实现多体数据的基于点的可视化
  • 批准号:
    20700096
  • 财政年份:
    2009
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Research Projects to Clarify the Molecular Pathogenesis and to Develop Therapeutic or Preventive Strategy for Cardiomyopathy
阐明心肌病分子发病机制并制定治疗或预防策略的研究项目
  • 批准号:
    19390208
  • 财政年份:
    2007
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Investigation of the molecular mechanisms of cardiac failure focusing on the Z-disc abnormalities
以Z盘异常为中心的心力衰竭分子机制研究
  • 批准号:
    16390219
  • 财政年份:
    2004
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification of Disease-associated Genes for Cardiovascular Diseases
心血管疾病相关基因的鉴定
  • 批准号:
    12204004
  • 财政年份:
    2000
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Regulation of ectopic expression of HLA class II genes.
HLA II 类基因异位表达的调节。
  • 批准号:
    01480192
  • 财政年份:
    1989
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Multicenter Trial of ECMO in Children with Severe Cardiac Failure using the Cardiohelp System
使用 Cardiohelp 系统对严重心力衰竭儿童进行 ECMO 多中心试验
  • 批准号:
    10861648
  • 财政年份:
    2023
  • 资助金额:
    $ 6.27万
  • 项目类别:
Common molecules that cause or prevent cardiac failure and periodontal disease exacerbation
引起或预防心力衰竭和牙周病恶化的常见分子
  • 批准号:
    21K10238
  • 财政年份:
    2021
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of DNA methylation in cardiac failure and recovery
DNA 甲基化在心力衰竭和恢复中的作用
  • 批准号:
    10227189
  • 财政年份:
    2020
  • 资助金额:
    $ 6.27万
  • 项目类别:
Role of DNA methylation in cardiac failure and recovery
DNA 甲基化在心力衰竭和恢复中的作用
  • 批准号:
    10641007
  • 财政年份:
    2020
  • 资助金额:
    $ 6.27万
  • 项目类别:
Role of DNA methylation in cardiac failure and recovery
DNA 甲基化在心力衰竭和恢复中的作用
  • 批准号:
    10455474
  • 财政年份:
    2020
  • 资助金额:
    $ 6.27万
  • 项目类别:
Investigation of NOX4-mediated mechanotransduction in mechanically-induced cardiac failure
NOX4介导的机械性心力衰竭中机械转导的研究
  • 批准号:
    20K12598
  • 财政年份:
    2020
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of DNA methylation in cardiac failure and recovery
DNA 甲基化在心力衰竭和恢复中的作用
  • 批准号:
    10055603
  • 财政年份:
    2020
  • 资助金额:
    $ 6.27万
  • 项目类别:
Research on pathogenesis and development of therapies for cardiac failure using dystrophin-deficient-cardiomyocytes derived from DMD patients
利用 DMD 患者抗肌营养不良蛋白缺陷型心肌细胞研究心力衰竭的发病机制和治疗方法
  • 批准号:
    18K07064
  • 财政年份:
    2018
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The utility of ultrasound and biochemical markers for the purpose of predicting cardiac failure in recipient's fetuses in twin-twin transfusion syndrome.
超声和生化标记物在预测双胎输血综合征受者胎儿心力衰竭中的应用。
  • 批准号:
    17K16875
  • 财政年份:
    2017
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Novel method for the evaluation of left ventricular diastolic function using intracardiac flow analysis in dog with cardiac failure
利用心内血流分析评估心力衰竭犬左心室舒张功能的新方法
  • 批准号:
    16K08047
  • 财政年份:
    2016
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了